Viiv Healthcare Release Date

Listing Websites about Viiv Healthcare Release Date

Filter Type:

ViiV Healthcare Announces US FDA Approval of - Business Wire

(Just Now) People also askWho owns ViiV Healthcare?ViiV Healthcare announces US FDA appr ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the US Food and Drug Administration (FDA) has approved Rukobia (fostemsavir), 600 mg extended-release tablets.ViiV Healthcare announces US FDA approval for Rukobia (fostemsavir), a us.gsk.comWhat's new at ViiV Healthcare?Kimberly Smith, M.D., MPH, Head of Research & Development at ViiV Healthcare, said: "As leaders in developing long-acting injectables for the treatment of HIV, we’re excited to present new data setting the stage for ViiV’s next generation of medicines and demonstrating how key pipeline assets will target HIV in different ways.ViiV Healthcare to present data for its next generation of ultra long finance.yahoo.comWhat does ViiV Healthcare do?We are part of the conversation: we listen; we hear; we learn. The voice of the HIV community informs everything we do to improve the lives of all people living with HIV, with an emphasis on those who most often get left behind. At ViiV Healthcare, our vision is to end the HIV epidemic and make sure no one living with HIV or AIDS is left behind.Our History & Mission ViiV Healthcare USviivhealthcare.comCan Pfizer buy ViiV Healthcare?* Under the ViiV Healthcare shareholder agreement, Pfizer has an option to request an initial public offering, which if not completed within nine months, will require GSK to acquire Pfizer’s shareholding in ViiV Healthcare. GSK is a science-led global healthcare company. For further information, please visit www.gsk.com/about-us .GSK announces settlement between ViiV Healthcare and Gilead Sciences us.gsk.comFeedbackViiV Healthcarehttps://viivhealthcare.com/en-us/media-center/news/LATITUDE phase III interim trial data indicates ViiV Healthcare’s …WebLondon, 21 February 2024 – ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced results from an interim analysis of the LATITUDE phase III trial, indicating their long …

https://www.businesswire.com/news/home/20220329005875/en/ViiV-Healthcare-Announces-US-FDA-Approval-of-Cabenuva-cabotegravir-rilpivirine-for-Virologically-Suppressed-Adolescents-Living-With-HIV-Who-Are-12-Years-of-Age-or-Older-and-Weigh-at-Least-35-kg#:~:text=March%2029%2C%202022%2001%3A30,PM%20Eastern%20Daylight%20Time

Category:  Food,  Medicine Show Health

ViiV Healthcare Announces Interim Data at CROI Indicating …

(4 days ago) WebLONDON, March 06, 2024--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced …

https://finance.yahoo.com/news/viiv-healthcare-announces-interim-data-170500968.html

Category:  Health Show Health

ViiV Healthcare to present data for its next generation of ultra long

(9 days ago) WebLONDON, February 28, 2024--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced the …

https://finance.yahoo.com/news/viiv-healthcare-present-data-next-150400807.html

Category:  Health Show Health

Statement—NIH Celebrates FDA Approval of Long-Acting …

(8 days ago) WebYesterday the U.S. Food and Drug Administration announced its first approval of a long-acting HIV prevention medication. Developed by ViiV Healthcare, the …

https://www.niaid.nih.gov/news-events/statement-nih-celebrates-fda-approval-long-acting-injectable-drug-hiv-prevention

Category:  Food Show Health

ViiV Healthcare to present data for its next generation of ultra long

(2 days ago) WebAbout ViiV Healthcare. ViiV Healthcare is a global specialist HIV company established in November 2009 by GSK (LSE: GSK) and Pfizer (NYSE: PFE) dedicated to …

https://us.gsk.com/en-us/media/press-releases/viiv-healthcare-to-present-data-for-its-next-generation-of-ultra-long-acting-treatments-for-hiv/

Category:  Health Show Health

ViiV Healthcare announces new packaging option now

(3 days ago) WebViiV Healthcare is a global specialist HIV company established in November 2009 by GSK (LSE: GSK) and Pfizer (NYSE: PFE) dedicated to delivering advances in …

https://www.businesswire.com/news/home/20240124470296/en/ViiV-Healthcare-announces-new-packaging-option-now-available-in-the-U.S.-for-Dovato-dolutegravirlamivudine

Category:  Health Show Health

ViiV Healthcare to present key data that provides further support …

(7 days ago) WebThis is an archived press release which may not reflect current medical knowledge and should not be used as a source of information on the present label, safety data or …

https://viivhealthcare.com/en-us/media-center/news/press-releases/2021/september/viiv-healthcare-to-present-key-data/

Category:  Medical Show Health

ViiV Healthcare announces US FDA approval of - Business Wire

(Just Now) WebAbout ViiV Healthcare ViiV Healthcare is a global specialist HIV company established in November 2009 by GlaxoSmithKline (LSE/NYSE: GSK) and Pfizer (NYSE: …

https://www.businesswire.com/news/home/20211220005863/en/ViiV-Healthcare-announces-US-FDA-approval-of-Apretude-cabotegravir-extended-release-injectable-suspension-the-first-and-only-long-acting-injectable-option-for-HIV-prevention

Category:  Health Show Health

ViiV Healthcare announces US FDA approval for Rukobia …

(4 days ago) WebViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the US Food and Drug …

https://us.gsk.com/en-us/media/press-releases/viiv-healthcare-announces-us-fda-approval-for-rukobia-fostemsavir-a-first-in-class-treatment-for-hiv-in-adults-with-few-treatment-options-available/

Category:  Food Show Health

ViiV Healthcare announces US FDA approval of Cabenuva …

(7 days ago) WebIt contains ViiV Healthcare’s cabotegravir extended-release injectable suspension in a single-dose vial and rilpivirine extended-release injectable suspension in …

https://us.gsk.com/en-us/media/press-releases/viiv-healthcare-announces-us-fda-approval-of-cabenuva-cabotegravir-rilpivirine-for-use-every-two-months-expanding-the-label-of-the-first-and-only-complete-long-acting-hiv-treatment/

Category:  Health Show Health

ViiV Healthcare Announces US FDA Approval of - Business Wire

(Just Now) WebViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi B.V. as shareholders,

https://www.businesswire.com/news/home/20220329005875/en/ViiV-Healthcare-Announces-US-FDA-Approval-of-Cabenuva-cabotegravir-rilpivirine-for-Virologically-Suppressed-Adolescents-Living-With-HIV-Who-Are-12-Years-of-Age-or-Older-and-Weigh-at-Least-35-kg

Category:  Health Show Health

ViiV Healthcare announces label update for its long-acting HIV

(8 days ago) WebAbout ViiV Healthcare. ViiV Healthcare is a global specialist HIV company established in November 2009 by GlaxoSmithKline (LSE: GSK) and Pfizer (NYSE: PFE) …

https://us.gsk.com/en-us/media/press-releases/viiv-healthcare-announces-label-update-for-its-long-acting-hiv-treatment-cabenuva-cabotegravir-rilpivirine-to-be-initiated-with-or-without-an-oral-lead-in-period/

Category:  Health Show Health

ViiV Healthcare announces FDA approval of Cabenuva …

(8 days ago) WebLynn Baxter, Head of North America, ViiV Healthcare, said: “Today’s FDA approval of Cabenuva represents a shift in the way HIV is treated, offering people living …

https://www.businesswire.com/news/home/20210121005951/en/ViiV-Healthcare-announces-FDA-approval-of-Cabenuva-cabotegravir-rilpivirine-the-first-and-only-complete-long-acting-regimen-for-HIV-treatment

Category:  Health Show Health

ViiV Healthcare to present data for its next generation of ultra long

(2 days ago) WebViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced the presentation o in a …

https://www.businesswire.com/news/home/20240223777191/en/ViiV-Healthcare-to-present-data-for-its-next-generation-of-ultra-long-acting-treatments-for-HIV

Category:  Health Show Health

ViiV Healthcare announces first global regulatory approval of

(1 days ago) WebIssued: London, UK. ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today …

https://us.gsk.com/en-us/media/press-releases/viiv-healthcare-announces-first-global-regulatory-approval-of-cabenuva-the-first-complete-long-acting-regimen-for-the-treatment-of-hiv/

Category:  Health Show Health

Our History & Mission ViiV Healthcare US

(4 days ago) WebThis is an archived press release which may not reflect current medical knowledge and should not be used as a source of information on the present label, safety data or …

https://viivhealthcare.com/en-us/about-viiv/history-and-mission/

Category:  Medical Show Health

ViiV Healthcare - Business Wire

(7 days ago) WebContacts. ViiV Healthcare enquiries: Media enquiries: Audrey Abernathy +1 919 605 4521 (North Carolina) Catherine Hartley +44 7909 002 403 (London) GSK …

https://www.businesswire.com/news/home/20220118006212/en/ViiV-Healthcare-Announces-US-FDA-Approval-of-Cabenuva-cabotegravir-rilpivirine-for-Use-Every-Two-Months-Expanding-the-Label-of-the-First-and-Only-Complete-Long-Acting-HIV-Treatment

Category:  Health Show Health

Filter Type: